KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Deferred Taxes (2016 - 2025)

Gilead Sciences' Deferred Taxes history spans 17 years, with the latest figure at -$122.0 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 67.81% year-over-year to -$122.0 million; the TTM value through Dec 2025 reached $160.0 million, up 108.68%, while the annual FY2025 figure was $160.0 million, 108.68% up from the prior year.
  • Deferred Taxes reached -$122.0 million in Q4 2025 per GILD's latest filing, down from $659.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $659.0 million in Q3 2025 to a low of -$723.0 million in Q1 2024.
  • Average Deferred Taxes over 5 years is -$215.7 million, with a median of -$245.5 million recorded in 2022.
  • Peak YoY movement for Deferred Taxes: skyrocketed 298.35% in 2021, then tumbled 1016.9% in 2022.
  • A 5-year view of Deferred Taxes shows it stood at -$359.0 million in 2021, then rose by 5.85% to -$338.0 million in 2022, then decreased by 9.47% to -$370.0 million in 2023, then fell by 2.43% to -$379.0 million in 2024, then surged by 67.81% to -$122.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Deferred Taxes are -$122.0 million (Q4 2025), $659.0 million (Q3 2025), and -$178.0 million (Q2 2025).